Cargando…
Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting
Recombinant adeno-associated viruses (rAAVs) have become one of the leading gene therapies for treating a variety of diseases. One factor contributing to rAAVs’ success is the fact that a wide variety of tissue types can be transduced by different serotypes. However, one commonality amongst most ser...
Autores principales: | Chan, Christopher, Harris, Kathryn K., Zolotukhin, Sergei, Keeler, Geoffrey D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675213/ https://www.ncbi.nlm.nih.gov/pubmed/38005848 http://dx.doi.org/10.3390/v15112168 |
Ejemplares similares
-
AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018) -
Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8
por: Cabanes-Creus, Marti, et al.
Publicado: (2021) -
Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System
por: Kondratov, Oleksandr, et al.
Publicado: (2023) -
T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021) -
AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)